Dr. Raffaele Corbisiero: Quadripolar Technology Quantum Leap in CRT Delivery

Posted on: May 9, 2014

Raffaele Corbisiero, MD, FACC, Chair of Electrophysiology, Deborah Heart and Lung Center, says that we can not accept the CRT 1/3 non-response rate.  He points to Quadripolar technology as a means to: significantly reduce the risks and complications associated with traditional Bipolar CRT, yield better patient outcomes and gain huge economic savings.  Studies on Bipolar vs. Quadripolar have found that Quadripolar technology has resulted in: 87% reduction in hospital cost utilization with a 10-fold savings using the SJM Quartet™ lead, reduction in heart failure events by 50% and an overall decrease in mortality rates.

This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.